Jay M Lee

Title: Jay M Lee - Innovator in Cancer Immunotherapy

Introduction

Jay M Lee is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of cancer treatment through his innovative research and patenting efforts. His work focuses on combination immunotherapy, which aims to enhance the effectiveness of cancer treatments.

Latest Patents

Jay M Lee holds a patent for a method of treating cancer in a mammal subject by administering a therapeutically effective amount of secondary lymphoid organ chemokine (SLC) in combination with a checkpoint inhibitor. This invention is based on the discovery that SLC inhibits the growth of syngeneic tumors in vivo. The patent outlines the use of various checkpoint molecules, including CTLA-4, PD-1, and OX40, among others. His innovative approach utilizes SLC polypeptides, variants, and related nucleic acids to improve cancer treatment outcomes. He has 1 patent to his name.

Career Highlights

Throughout his career, Jay M Lee has worked with esteemed institutions such as the University of California and the United States Government as represented by the Department of Veterans Affairs. His research has been pivotal in advancing the understanding of immunotherapy and its applications in oncology.

Collaborations

Jay M Lee has collaborated with notable colleagues, including Steven M Dubinett and Sherven Sharma. These partnerships have contributed to the development of innovative cancer therapies and have enhanced the impact of his research.

Conclusion

Jay M Lee is a dedicated inventor whose work in combination immunotherapy represents a significant advancement in cancer treatment. His innovative approaches and collaborations continue to influence the field and offer hope for improved therapeutic strategies.